Hair Loss Study: Understanding Male Pattern Baldness
Part of Skin clinical trials.
This research study examines what causes male pattern baldness (androgenetic alopecia) by studying hair, skin, and biological samples from men with hair loss and healthy men. The goal is to better understand why hair loss happens so scientists can develop better treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a male aged 25–30 or 60–65 years old
- You have moderate hair loss (Hamilton-Norwood Stage III, meaning hair loss on the crown and front)
- You have not used hair loss medications (like minoxidil or finasteride) or hormonal drugs in the last 6 months
- You have not had chemical treatments like perms or dyes on your scalp in the last 6 months
- You do not have other scalp conditions (psoriasis, dermatitis, infections) or other types of hair loss
- You do not have serious health conditions like heart disease, immune disorders, cancer, blood clotting problems, or keloids
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug, OLX72021, given as injections into the scalp, to see if it can help regrow hair in men with male pattern baldness. It will also check how safe the drug is and how well it works.
This study tests a new scalp solution (KX-826) for men with androgenetic alopecia, commonly known as male pattern baldness. It aims to see if the solution can help regrow hair and is safe to use. Participants will apply the solution to their scalp and have their hair growth monitored over time.
This study tests an oral pill form of minoxidil, a common hair growth treatment, for men with male pattern baldness. It aims to see if the pill is safe and effective in helping hair regrow.
This trial tests if injecting donor stem cells into the scalp can help regrow hair in men with male pattern baldness. It may offer a new option for those who haven't found other treatments effective.
This trial tests a new treatment using exosomes (tiny particles that help cells communicate) for male pattern baldness. It may help regrow hair or slow further loss.
This trial tests a low-dose oral form of minoxidil (a hair growth medicine) for people with pattern hair loss. It aims to see if this treatment helps regrow hair in a convenient way.
Hear when a new Androgenetic Alopecia (AGA) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.